Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
CA75103L1013
Wed, 02.04.2025
Rakovina Therapeutics Inc.
Company Name:
Rakovina Therapeutics Inc.
ISIN:
CA75103L1013
Reason for the research:
Initiation of coverage
Recommendation:
Buy
from:
02.04.2025
Target price:
0,40 CAD
Target price on sight of:
12 Months
Last rating change:
-
Analyst:
Alexander RIhane
First Berlin Equity Research hat am 02.04.2025 die Coverage von Rakovina The [ … ]